OAC
ACTU

OMERS Administration Corp’s Actuate Therapeutics ACTU Stock Holding History

OMERS Administration Corp’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,583
Closed -$84.2K – 1144
2024
Q4 		$84.2K Buy
+10,583
New +$86.4K ﹤0.01% 912

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NU
Northwestern University Evanston, Illinois $63.3M AUM 0.76% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OMERS Administration Corp's ACTU Position: Q1 2025 in Review

OMERS Administration Corp sold out of Actuate Therapeutics (ACTU) in Q1 2025, closing a stake of 10,583 shares — an estimated $84.2K sold.

OMERS Administration Corp first reported a position in ACTU in Q4 2024 and held it in 1 quarter. The position peaked at $84.2K in Q4 2024. 25 funds tracked by Wall St. Rank hold ACTU as of Q1 2025.

  • OMERS Administration Corp reported no remaining Actuate Therapeutics position as of Q1 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 10,583 Actuate Therapeutics shares in Q1 2025, an estimated $84.2K.
  • OMERS Administration Corp first reported a position in Actuate Therapeutics in Q4 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Actuate Therapeutics position peaked at $84.2K in Q4 2024.
  • 25 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2025.

Based on OMERS Administration Corp's 13F filing for Q1 2025, filed 14 May 2025.